{
  "id": "spirometry",
  "title": "Spirometry",
  "lang": "en",
  "source_lang": "en",
  "summary": "Spirometry measures the volume and flow of air breathed in and out, helping assess lung function and identify patterns of airflow obstruction.",
  "category": "health",
  "subcategory": "medicine",
  "type": "concept",
  "aliases": [
    "Spirometric testing"
  ],
  "generated_at": "2026-11-05",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/spirometry/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/spirometry/",
      "json": "https://aiwiki.page/zh/spirometry.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "Spirometry is a pulmonary function test that measures the volume of air a person inhales or exhales and how quickly air moves during breathing. Its principal measurements describe a forceful exhalation after a maximal inhalation. Spirometry is used in the assessment of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. It measures aspects of ventilatory function rather than directly showing lung structure or measuring gas exchange."
    },
    {
      "heading": "Principles and equipment",
      "text": "A spirometer records changes in volume, airflow, or both. Volume-displacement instruments measure the movement of a chamber or bell, while flow-sensing instruments measure airflow and calculate volume by integrating flow over time. Modern devices commonly use differential-pressure sensors, turbines, or ultrasonic measurement.\n\nResults are displayed principally as:\n\n- Volume–time curves, showing the accumulated volume exhaled against elapsed time.\n- Flow–volume loops, showing airflow against the volume inhaled or exhaled.\n\nThe shape of these curves helps identify airflow limitation and technical problems. Obstructive lung disease often produces a concave expiratory limb on the flow–volume loop. Flattening of parts of the loop can suggest obstruction in a larger airway, although curve shape alone does not establish a diagnosis.\n\nAccurate measurement depends on equipment performance, calibration verification, environmental corrections, and a well-performed breathing maneuver. Reported volumes are generally expressed at body temperature and ambient pressure, saturated with water vapor, a convention abbreviated BTPS."
    },
    {
      "heading": "Main measurements",
      "text": "Measurement | Meaning | Principal significance\nForced vital capacity (FVC) | Total volume exhaled during a forced expiration after maximal inspiration | Describes the volume expelled; a low value has several possible explanations\nForced expiratory volume in one second (FEV₁) | Volume exhaled during the first second of the FVC maneuver | Quantifies expiratory performance and helps characterize functional impairment\nFEV₁/FVC ratio | Proportion of the FVC exhaled in the first second | Central to identifying airflow obstruction\nPeak expiratory flow (PEF) | Highest flow achieved during forced expiration | Particularly sensitive to the initial effort and technique\nVital capacity (VC) | Maximum volume exhaled or inhaled during a complete maneuver, which may be performed slowly | Can provide additional information when compared with FVC\n\nFEV₁ and FVC are usually reported in liters, and their ratio may be expressed as a decimal or percentage. Mid-expiratory flow measurements, such as FEF₂₅–₇₅, are sometimes reported, but are variable and depend strongly on the measured FVC. They do not independently establish small-airway disease.\n\nSpirometry does not directly measure residual volume, the air remaining after maximal expiration. Consequently, it cannot directly determine total lung capacity or functional residual capacity, which require other measurement methods."
    },
    {
      "heading": "Test procedure and quality control",
      "text": "During conventional forced spirometry, the person breathes through a mouthpiece with a tight seal, usually while seated and wearing a nose clip. After inhaling as fully as possible, the person exhales with a rapid, forceful start and continues until an acceptable end of expiration is reached. Some protocols include a maximal inhalation afterward to complete the flow–volume loop.\n\nSeveral attempts are collected because results depend on coordination, understanding, effort, and biological variability. Technical assessment distinguishes:\n\n- Acceptability: whether an individual maneuver meets criteria for its start, execution, and, where relevant, completion.\n- Repeatability: whether the best measurements from separate maneuvers agree sufficiently.\n\nA hesitant start, leakage around the mouthpiece, obstruction by the tongue, glottic closure, or premature termination may affect results. A cough during the first second can invalidate FEV₁ even when other parts of the maneuver remain usable.\n\nThe 2019 American Thoracic Society and European Respiratory Society technical standard sets a goal of at least three acceptable FEV₁ measurements and three acceptable FVC measurements. For people older than six years, the two largest acceptable FEV₁ values should differ by no more than 150 mL, and the same criterion applies separately to FVC. Younger children have age-specific criteria.\n\nThe largest acceptable FEV₁ and largest acceptable FVC are reported even if they come from different attempts. Quality grades indicate the confidence warranted by the measurements; a numerical result without adequate quality assessment can be misleading."
    },
    {
      "heading": "Interpretation",
      "text": "Spirometry is interpreted alongside symptoms, medical history, exposures, physical examination, and other findings. A spirometric pattern describes physiology, not necessarily a specific disease.\n\nReference values\n\nMeasured values are compared with reference equations that account for factors such as age, height, and sex. Reports may include predicted values, percentages of predicted values, lower limits of normal, and z-scores.\n\nA z-score expresses how far a measurement lies from the reference population’s expected value, accounting for the distribution of values. The lower limit of normal is commonly set at the fifth percentile, approximately a z-score of \\(-1.645\\). It is a statistical boundary rather than a sharp biological separation between health and disease.\n\nUsing a universal cutoff such as 80% of predicted does not provide an equivalent definition of abnormality across all ages and measurements.\n\nObstructive pattern\n\nAirflow obstruction is characterized by an FEV₁/FVC ratio below the applicable lower limit of normal. FEV₁ helps quantify the degree of functional impairment, but does not by itself identify its cause.\n\nSome disease-specific frameworks use a fixed post-bronchodilator FEV₁/FVC threshold below 0.70 for COPD. Unlike an age-adjusted lower limit, this fixed threshold can classify more older people and fewer younger people as having obstruction. COPD diagnosis also requires an appropriate clinical context.\n\nPossible restrictive and mixed patterns\n\nA reduced FVC with a preserved or increased FEV₁/FVC ratio can suggest restriction, but spirometry alone cannot confirm restrictive ventilatory impairment. Confirmation requires a reduced total lung capacity.\n\nLow FVC may also result from incomplete inhalation, early termination, respiratory muscle weakness, or air trapping. Likewise, a low ratio accompanied by a low FVC does not establish a mixed obstructive–restrictive disorder unless reduced total lung capacity is demonstrated.\n\nNormal spirometry does not exclude all respiratory disease. Asthma between symptomatic episodes, early structural disease, and disorders affecting gas exchange may occur with normal spirometric measurements."
    },
    {
      "heading": "Bronchodilator responsiveness",
      "text": "Spirometry may be performed before and after administration of a bronchodilator, such as salbutamol, to measure changes in expiratory function.\n\nThe 2022 European Respiratory Society and American Thoracic Society interpretive standard defines a significant bronchodilator response as an increase in FEV₁ or FVC greater than 10% of that measurement’s predicted value:\n\n\\[\\text{Response} = \\frac{\\text{post-bronchodilator value}-\\text{pre-bronchodilator value}} {\\text{predicted value}}\\times100\\%.\\]\n\nThis differs from the older criterion of an increase of at least 12% and 200 mL relative to the baseline measurement. Criteria differ between technical standards and disease-specific guidelines, so the definition used affects classification.\n\nA positive response does not uniquely identify asthma, and a negative response does not exclude it. Bronchodilator responsiveness can also occur in COPD."
    },
    {
      "heading": "Clinical and occupational uses",
      "text": "Spirometry contributes to the investigation of persistent breathlessness, cough, and suspected airflow limitation. It is used to monitor respiratory function in established disease, including asthma, COPD, and cystic fibrosis, and in selected assessments before surgery.\n\nRepeated measurements can reveal changes over time, although interpretation must distinguish genuine change from measurement variability and differences in testing conditions. Occupational programs use spirometry to monitor workers exposed to respiratory hazards, including dusts associated with silicosis.\n\nDiagnostic testing in symptomatic people differs from population screening. The ability to detect airflow limitation does not, by itself, establish that screening an asymptomatic population improves health outcomes."
    },
    {
      "heading": "Limitations, safety, and reference-equation issues",
      "text": "Spirometry requires active cooperation. Some young children and people with cognitive, facial, neuromuscular, or severe respiratory limitations cannot perform a standard maneuver reliably.\n\nForced expiration briefly raises pressure within the chest and abdomen. Testing can provoke coughing, light-headedness, or, occasionally, fainting. Recent surgery and some unstable cardiovascular or respiratory conditions are among the circumstances considered in procedural risk assessment. Equipment hygiene and infection-control procedures are important because testing involves shared respiratory equipment and may provoke coughing.\n\nReference equations introduce additional uncertainty. Historically, many incorporated racial or ethnic categories. These categories do not represent discrete biological populations, and equation selection can change reported impairment classifications. Race-neutral reference equations have been developed and endorsed by professional societies. Reports are therefore more interpretable when they identify the equation used, particularly when comparing measurements across institutions or over time."
    },
    {
      "heading": "Historical development",
      "text": "In 1846, the British physician John Hutchinson described a spirometer and investigated vital capacity, including its relationship with height and other characteristics. His instrument helped establish quantitative measurement of respiratory function.\n\nDuring the twentieth century, timed forced expiratory measurements—especially FEV₁ and its relationship to vital capacity—became central to identifying airflow obstruction. Electronic flow sensors and computerized analysis subsequently made spirometry portable and enabled immediate curve display, automated calculations, and quality checks. These systems assist measurement but do not replace assessment of maneuver quality and clinical context."
    }
  ],
  "links": [
    "asthma",
    "calibration",
    "cough",
    "medical-history",
    "physical-examination",
    "diagnosis",
    "salbutamol",
    "shortness-of-breath",
    "cystic-fibrosis",
    "surgery",
    "silicosis",
    "medical-screening"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}